$MTVA Cashflow Statement | Understand Stock

$MTVA

$1.14 -$0.01 (0.87%) Close

$MTVA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation
Non-cash lease expense
Non-cash lease (credit) charge
Depreciation
Loss on sale of property and equipment
Acquired in-process research and development
Transaction costs allocated to issuance of warrants
Gain from change in fair value of warrant liabilities
Change in operating assets and liabilities
Prepaid expenses and other assets
Accounts payable
Accrued and other liabilities

Net cash used in operating activities
Investing activities
Transaction costs in connection with asset acquisitions
Purchases of property and equipment
Sale of property and equipment
Net cash used in investing activities

Financing activities
Proceeds from equity offering
Proceeds from issuance of common stock, preferred stock and warrants
Proceeds from the issuance of common stock and warrants under the securities purchase agreements from a private placement offering
Proceeds from exercise of warrants
Payments of issuance costs in connection with the securities purchase agreements
Exercise of stock options
Payment of employee withholding taxes related to shares withheld from issuance for vested restricted stock units
Net cash provided by financing activities

Net decrease in cash and cash equivalents
Net foreign exchange difference
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental non-cash investing and financing transactions:
Fair value of warrants issued to placement agent
Right-of-use assets obtained in exchange for operating lease liabilities
Modification of right-of-use asset and associated liability
Unpaid deferred issuance costs
Reclassification of warrant liabilities upon exercise of warrants

Comments